RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $277,000 | +31.3% | 12,401 | +75.9% | 0.01% | +25.0% |
Q1 2022 | $211,000 | -8.3% | 7,051 | -3.4% | 0.00% | 0.0% |
Q3 2021 | $230,000 | -42.4% | 7,300 | -36.8% | 0.00% | -42.9% |
Q1 2021 | $399,000 | -69.9% | 11,548 | -63.8% | 0.01% | -70.8% |
Q4 2020 | $1,325,000 | -20.0% | 31,870 | -18.1% | 0.02% | -51.0% |
Q3 2020 | $1,657,000 | – | 38,907 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
Grace Capital | 164,389 | $6,832,000 | 4.32% |
Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |